Integrative analysis of LC-MS based glycomic and proteomic data

Area of Science:

• Biochemistry
• Proteomics
• Glycomics
• Cancer Biomarkers

Background:

• Cancer biomarker research often focuses on individual molecules like glycans or proteins.
• Liquid chromatography mass spectrometry (LC-MS) facilitates high-throughput analysis of these biomolecules.
• The combined diagnostic potential of glycan and protein data remains largely unexplored.

Purpose of the Study:

• To investigate the integrative analysis of glycans and proteins for improved liver cancer detection.
• To leverage complementary information from both glycomic and proteomic data.
• To enhance the ability to distinguish liver cancer cases from controls.

Main Methods:

• Utilized Support Vector Machine-Recursive Feature Elimination (SVM-RFE) algorithm for feature selection.
• Analyzed N-glycans and proteins from serum samples using LC-MS data.
• Applied integrative analysis to datasets from two liver cancer study cohorts.

Main Results:

• Integrative analysis demonstrated improved performance in distinguishing liver cancer from liver cirrhosis.
• Combined glycomic and proteomic analysis outperformed separate analyses.
• Identified a panel of N-glycans and proteins with enhanced diagnostic capability.

Conclusions:

• Integrative glycan and protein analysis offers superior diagnostic performance for liver cancer.
• Combining glycomic and proteomic data provides complementary insights for biomarker discovery.
• This approach enhances the potential for developing more accurate liver cancer diagnostic tools.